XTL Biopharmaceuticals to Acquire Psyga Bio, Establishing a Leading Psychedelic Biotechnology Platform with Advanced Clinical Pipeline, Licensed GMP Manufacturing and Proprietary Psilocybin Technologies
Transaction Positions XTL at the Forefront of the Rapidly Expanding Global Psychedelic…
TV Rheinland Opens Advanced Automotive Component Testing Laboratory in Manesar, Haryana
Empowering automotive industry capabilities through precision testing, international compliance, and innovative solutions…
HCLTech FY26 revenue up 3.9%, led by increasing demand for Advanced AI
Annualized Advanced AI revenue at $620M; FY26 services revenue up 4.8% in…
Delska Launches One of the Baltics’ Most Advanced and Sustainable Data Centers in Riga
RIGA, Latvia, April 15, 2026 /PRNewswire/ -- Today, Delska, one of the…
Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma
April 10, 2026 17:02 ET | Source: Replimune, Inc. WOBURN, Mass., April…
ANSR Launches Healthcare GCC Accelerator Powered by Advanced AI Capabilities
New offering enables healthcare enterprises to build AI-enabled global capability centers by…
IISc Partners with CADFEM and Synopsys to Launch Advanced Simulation Center of Excellence at CeNSE
BENGALURU, India, March 26, 2026 /PRNewswire/ -- Ultra-high-speed electronic systems are increasingly shaping…
Bybit Enhances AI Trading Skills Hub with Copy Trading, Advanced Bots, and Institutional-Grade Security Upgrades
DUBAI, UAE, March 20, 2026 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency…
Pilgrim’s ‘Nani Ka Secret’ campaign featuring Rashmika Mandanna blends Indian nostalgia with Advanced Hair Growth Serum
Pilgrim's latest campaign showcases its popular Advanced Hair Growth Serum – one…
Imprivata Introduces New Advanced Access Management and Passwordless Authentication Capabilities to Enhance Clinical Efficiency, Security, and Essential Eight Compliance
MELBOURNE, March 16, 2026 (GLOBE NEWSWIRE) -- Imprivata, a leading provider of…
